Minimally invasive surgery reduces complications in gastric cancer treatment

Among 4,429 patients undergoing gastric adenocarcinoma resection (2016-2022), minimally invasive surgery (MIS) was linked to lower complication rates compared to open gastrectomy, with fewer major complications (13.1% vs. 18.5%) and reduced perioperative mortality (0.57% vs. 1.53%). Despite these benefits, MIS utilization remained stagnant, indicating a persistent preference for open surgery. Disparities in treatment access persist, with non-white patients less likely to receive MIS.